repaglinide
/ɹəˈpæɡ.lɪˌnaɪd/
Meaning
A meglitinide drug C₂₇H₃₆N₂O₄ (trademark Prandin) that stimulates insulin release and is taken orally to treat type 2 diabetes.
Etymology
From repa- (of unknown origin) + glinide.